Menglu Dong
Overview
Explore the profile of Menglu Dong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
191
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dong M, Liang X, Zhu T, Xu T, Xie L, Feng Y
Nat Sci Sleep
. 2024 May;
16:517-530.
PMID: 38812701
Background: Obstructive sleep apnea (OSA) is a prevalent sleep breathing disorder characterized by intermittent hypoxia (IH), with continuous positive airway pressure (CPAP) as its standard treatment. However, the effects of...
2.
Wang G, Du Y, Cui X, Xu T, Li H, Dong M, et al.
Cell Prolif
. 2024 Mar;
57(8):e13634.
PMID: 38494923
Differentiation of human embryonic stem cells (hESCs) into human embryonic stem cells-derived parathyroid-like cells (hESC-PT) has clinical significance in providing new therapies for congenital and acquired parathyroid insufficiency conditions. However,...
3.
Wu L, Wang Q, Li Y, Yang M, Dong M, He X, et al.
ACS Appl Mater Interfaces
. 2023 Sep;
15(37):44596.
PMID: 37671792
No abstract available.
4.
Yang X, Wu Y, Xu S, Li H, Peng C, Cui X, et al.
BMC Endocr Disord
. 2023 May;
23(1):113.
PMID: 37208644
Background: Recurrent and metastatic thyroid cancer is more invasive and can transform to dedifferentiated thyroid cancer, thus leading to a severe decline in the 10-year survival. The thyroid-stimulating hormone receptor...
5.
Lv W, He X, Wang Y, Zhao C, Dong M, Wu Y, et al.
Sci Rep
. 2023 Apr;
13(1):6403.
PMID: 37076508
Breast cancer (BC) is one of the most common malignancies. However, the existing pathological grading system cannot accurately and effectively predict the survival rate and immune checkpoint treatment response of...
6.
Cui X, Yang X, Wang G, Li H, Li S, Xu T, et al.
Life Sci
. 2022 Sep;
309:120993.
PMID: 36162484
Heading Aims: Breast cancer is one of the most common malignant tumors with a high incidence and leading cancer-related death in women worldwide. MiR-205 plays a crucial role in breast...
7.
Zhou M, Dong M, Yang X, Gong J, Liao X, Zhang Q, et al.
Front Genet
. 2022 Aug;
13:983564.
PMID: 36035182
Breast cancer (BC) has continued to be the leading cause of cancer deaths in women, accompanied by highly molecular heterogeneity. N6-methyladenosine (m6A), a methylation that happens on adenosine N6, is...
8.
Dong M, Cui X, Wang G, Zhang Q, Li X
Aging (Albany NY)
. 2022 Jul;
14(13):5427-5448.
PMID: 35793235
Breast cancer (BC) is an inflammatory tumor caused by a variety of pathological factors, and is still the most common malignant tumor in women. Immune-related genes (IRGs) play a prominent...
9.
Dong M, Liu Q, Xu Y, Zhang Q
Front Cell Dev Biol
. 2022 Mar;
10:842898.
PMID: 35300426
Triple-negative breast cancer (TNBC) is a heterogeneous subtype of breast cancer (BC) with diverse biological behavior, high aggressiveness, and poor prognosis. Extracellular vesicles (EVs) are nano-sized membrane-bound vesicles secreted by...
10.
Analysis of m6A Methylation Modification Patterns and Tumor Immune Microenvironment in Breast Cancer
Dong M, Shen W, Yang G, Yang Z, Li X
Front Cell Dev Biol
. 2022 Feb;
10:785058.
PMID: 35178386
Increasing evidence indicates that the abnormal expression of N6-methyladenosine (m6A) modification is closely related to the epigenetic regulation of immune response in breast cancer (BC). However, the potential roles of...